Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.775 USD | +0.18% | -2.64% | -32.27% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.27% | 367M | |
+43.09% | 54.04B | |
+43.57% | 41.96B | |
-1.30% | 41.92B | |
-7.59% | 28.35B | |
+11.79% | 26.35B | |
-21.86% | 19B | |
+7.69% | 13B | |
+28.94% | 12.28B | |
+26.01% | 12.19B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Organogenesis : Oppenheimer Adjusts Price Target on Organogenesis Holdings to $13 From $9, Maintains Outperform Rating